|
Orthologous residues
|
|
STAT5A (human): Y694‑p, STAT5A (mouse): Y694‑p, STAT5A iso2 (mouse): ‑, STAT5A (rat): Y694‑p, STAT5A (fruit fly): Y711‑p, STAT5A (sheep): Y694‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
flow cytometry, phospho-antibody
|
|
Disease tissue studied:
leukemia, chronic myelogenous leukemia
|
|
Relevant cell lines - cell types - tissues:
K562 (erythroid)
|
|
Cellular systems studied:
cell lines
|
|
Species studied:
human
|
|
Upstream Regulation
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
imatinib
|
|
|
|
decrease
|
|
|